Assessing research results in the medical literature: Trust but verify

JAMA Internal Medicine

Volumn 173, Issue 12, 2013, Pages 1053-1055

  Califf, Robert M ^a   McCall, Jonathan ^b   Harrington, Robert A ^c  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMEDICINE; EVIDENCE BASED PRACTICE; HEALTH CARE POLICY; MEDICAL LITERATURE; MEDICAL RESEARCH; PRACTICE GUIDELINE; PRIORITY JOURNAL; PUBLICATION; RISK BENEFIT ANALYSIS; SHORT SURVEY;

BIOMEDICAL RESEARCH; CALIFORNIA; CLINICAL TRIALS AS TOPIC; CONFLICT OF INTEREST; EVIDENCE-BASED MEDICINE; HUMANS; NORTH CAROLINA; PEER REVIEW, RESEARCH; PUBLICATION BIAS; RESEARCH REPORT; SOCIAL RESPONSIBILITY; TRUST; UNITED STATES;

EID: 84879566850     PISSN: 21686106     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamainternmed.2013.829     Document Type: Short Survey

References (9)

1. Krumholz HM. Open science and data sharing in clinical research: basing informed decisions on the totality of the evidence. Circ Cardiovasc Qual Outcomes. 2012;5(2):141-142.
2. Ioannidis JP. Why most published research findings are false. PLoS Med. 2005;2(8):e124.
3. Institute of Medicine. Summary: findings, conclusions, and recommendations. In: Micheel CM, Nass SJ, Omenn GS, eds. Evolution of Translational Omics: Lessons Learned and the Path Forward. Washington, DC: National Academies Press; 2012. http://books.nap.edu/openbook.php?record-id= 13297. Accessed January 24, 2013.
4. Rising K, Bacchetti P, Bero L. Reporting bias in drug trials submitted to the Food and Drug Administration: review of publication and presentation. PLoS Med. 2008;5(11):e217.
5. Prinz F, Schlange T, Asadullah K. Believe it or not: how much can we rely on published data on potential drug targets? Nat Rev Drug Discov. 2011;10(9):712.
6. Coombes KR, Wang J, Baggerly KA. Microarrays: retracing steps. Nat Med. 2007;13(11):1276-1277.
7. Califf RM, Kornbluth S. Establishing a framework for improving the quality of clinical and translational research. J Clin Oncol. 2012;30(14):1725-1726.
8. Califf RM, Zarin DA, Kramer JM, Sherman RE, Aberle LH, Tasneem A. Characteristics of clinical trials registered in ClinicalTrials.gov, 2007-2010.2012;307(17):1838-1847.
9. Ross JS, Tse T, Zarin DA, Xu H, Zhou L, Krumholz HM. Publication of NIH funded trials registered in ClinicalTrials.gov: cross sectional analysis. BMJ. 2012;344:d7292.